Phase 3 Readout~month

Phase 3 Topline: Study of Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency

Indication
Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency

Other upcoming events for MCUJF

Patent ExpiryPatent/Exclusivity Expiry: ZYPITAMAG

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: Study of Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency — MCUJF Phase 3 Readout | BioSniper